October 9th 2025, 8:00pm
Young women with breast cancer experience significant declines in body image, sexual satisfaction, and sexual interest both during and after treatment.
October 9th 2025, 7:00pm
Dr. Vishal Patel explains what Libtayo’s FDA approval means for patients with high-risk cutaneous squamous cell carcinoma.
October 9th 2025, 5:00pm
As a survivor, I see pink ribbons everywhere, but what we really need is more research, better treatments, and real change for those living with cancer.
October 9th 2025, 3:59pm
Dr. Patrick J. Hensley explains non-muscle invasive bladder cancer, bladder-preserving treatments, trial eligibility, novel therapies and research priorities for patients.
October 9th 2025, 3:00pm
The FDA granted fast track designation to VT3989 for unresectable malignant nonpleural or pleural mesotherlioma.
October 9th 2025, 1:00pm
Dr. Ravi Munver highlights how minimally invasive treatment has improved recovery and quality, improving outcomes for patients with kidney cancer
October 8th 2025, 9:00pm
Remote monitoring has been found to be associated with improved postsurgical recovery for patients with cancer.
October 8th 2025, 8:00pm
Dr. Sheldon Marc Feldman explores Reiki’s potential to reduce stress and anxiety for patients undergoing breast cancer surgery at Montefiore Einstein Comprehensive Cancer Center.
October 8th 2025, 7:04pm
The FDA has approved Libtayo for the postsurgical treatment of adults with cutaneous squamous cell carcinoma.
October 8th 2025, 5:00pm
At the age of 34, I received the biggest news of my life, which was my diagnosis with colon cancer. I remember that day like it was yesterday.
Finding Humor in a Cancer Journey
Pancreatic Cancer on the Rise Among Younger Adults
Covering Every FDA Oncology Approval From October 2025
Why ‘There is Hope’ For Patients With Pancreatic Cancer